Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery
In the laboratory of C. M. O’Driscoll (University College Cork), an antibody targeted cyclodextrin-based siRNA delivery vector (CD.DSPE-PEGFab) was developed
Symmetrical conformers of naturally occurring cyclodextrins
Due to the high flexibility of the glucose units CDs can be described by many conformers. Recent advances in high-performance
Opinion leaders of CD society getting together in Budapest
In the recent two weeks, Cyclolab had the pleasure to welcome two prominent pioneers of cyclodextrin research, Prof. Loftsson from
CD-related project received award for the best coordination
CyclonHit project was awarded for the best coordination as it went beyond the initially planned objectives, it highly involved women
Protecting groups: Strategies and Applications in Carbohyrate Chemistry
The new book edited by Prof. Sébastien Vidal (University of Lyon) contains 17 chapters on various strategies and applications including
Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery
In the laboratory of C. M. O’Driscoll (University College Cork), an antibody targeted cyclodextrin-based siRNA delivery vector (CD.DSPE-PEGFab) was developed
CDs are everywhere, even on the blog of Chancellor of Germany!
To my greatest surprise a cyclodextrin-related blog post may be found on the Bundeskanzlerin’s website. Angela Merkel awarded two young
NO-releasing cyclodextrins
Nitric oxide (NO) is a signaling molecule produced by almost all types of organisms ranging from bacteria to plants and
Mannose with anti-cancer effect
In a recently published Nature report it was investigated how tumor cells respond to different forms of sugar [1]. It
Self-decontaminating biocatalyst against nerve gases
Chemical warfare agents (CWA) are one of the most brutal weapons created by mankind [1]. CWAs are inexpensive and are
Cyclodextrins involved in clinical trials to start
According to clinicaltrials.gov, currently, there are 14 cyclodextrin-related clinical trials that in the status of i) Not yet recruiting, ii)